Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain
Phase 1
Completed
- Conditions
- NeuralgiaMyalgia
- Interventions
- Drug: CunermuspirOther: Placebo
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- Mitosynergy LLC
- Target Recruit Count
- 56
- Registration Number
- NCT04737278
- Locations
- 🇨🇦
KGK Synergize now KGK Science, London, Ontario, Canada
News
No news found